Seaford Pharmaceuticals Private Limited
About Seaford Pharmaceuticals Private Limited
Data last updated:
Seaford Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 23 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC120182. Its GSTIN is 36AAZCS3834J1ZL (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Syed Mohammed Abubakar Suffyan and Asma Sultana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #H.No:6 – 66/27 Khizra Enclave Puppalguda, Hyderabad, Telangana, India – 500075.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.34 Lakh, a decline of 10% compared to the previous year. For the same year it recorded a net loss of ₹1.81 Lakh (net margin -33.9%) and EBITDA of -₹1.81 Lakh (EBITDA margin -33.9%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Seaford Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered Address#H.No:6 – 66/27 Khizra Enclave Puppalguda, Hyderabad, Telangana, India – 500075
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Seaford Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Seaford Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Seaford Pharmaceuticals Private Limited, buy the company report.
Financials of Seaford Pharmaceuticals Private Limited
FY 2025 filings availableSeaford Pharmaceuticals Private Limited reported revenue of ₹5.34 Lakh (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 10% fall in the latest year. EBITDA fell 239% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -33.9% | ||||
| Net Profit Margin | -33.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seaford Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seaford Pharmaceuticals Private Limited
Seaford Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Mohammed Abubakar Suffyan | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
| Asma Sultana | Director | 23 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Seaford Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunvet Homoeo Pharmaceuticals Private Limited | ₹5.35 Lakh (FY 2025) | -4.0% | West Bengal, India | |||
| Solvocare Pharmaceuticals Private Limited | ₹5.34 Lakh (FY 2024) | -14.0% | Chapra, Bihar, India | |||
| Seaford Pharmaceuticals Private Limitedthis company | ₹5.34 Lakh (FY 2024) | -₹1.81 Lakh | -33.9% | -10.0% | Hyderabad, Telangana, India | |
| Novosol Pharmaceuticals Private Limited | ₹5.33 Lakh (FY 2016) | -58.0% | Gorakhpur, Uttar Pradesh, India | |||
| Palvik Pharmaceuticals Private Limited | ₹5.32 Lakh (FY 2017) | 19.0% | Delhi, India |
To see the full peer comparison of Seaford Pharmaceuticals Private Limited, buy the company report.
Auditor
Seaford Pharmaceuticals Private Limited is audited by B D R & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B D R & ASSOCIATES | FY 2021 | 017133S |
Shareholding
The shareholding of Seaford Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Seaford Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Seaford Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seaford Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Seaford Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAZCS3834J1ZL | Telangana | Active | 01 Dec 2017 |
To see the full GST registrations and return filing status of Seaford Pharmaceuticals Private Limited, buy the company report.
Recent activity
Seaford Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Asma Sultana was appointed as Director on 23 Oct 2017.
Frequently asked questions
Seaford Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 23 October 2017 (9+ years old) and is registered under CIN U74999TG2017PTC120182.
Seaford Pharmaceuticals has 2 current directors:
- Syed Mohammed Abubakar Suffyan - Director
- Asma Sultana - Director
The latest financial statements of Seaford Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Seaford Pharmaceuticals is 36AAZCS3834J1ZL, registered in Telangana.
The CIN (Corporate Identification Number) of Seaford Pharmaceuticals is U74999TG2017PTC120182. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seaford Pharmaceuticals was incorporated on 23 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Seaford Pharmaceuticals by revenue are Sunvet Homoeo Pharmaceuticals Private Limited, Solvocare Pharmaceuticals Private Limited, Novosol Pharmaceuticals Private Limited, Palvik Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Asma Sultana was appointed as Director on 23 Oct 2017. Syed Mohammed Abubakar Suffyan was appointed as Director on 23 Oct 2017.
The registered office of Seaford Pharmaceuticals is at #H.No:6 – 6627 Khizra Enclave Puppalguda, Hyderabad, Telangana, India – 500075.
Seaford Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Seaford Pharmaceuticals is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
